Hims & Hers Health (NYSE:HIMS – Get Free Report) and SBC Medical Group (NASDAQ:SBC – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations.
Risk & Volatility
Hims & Hers Health has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Comparatively, SBC Medical Group has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent recommendations for Hims & Hers Health and SBC Medical Group, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Hims & Hers Health | 1 | 8 | 8 | 0 | 2.41 |
| SBC Medical Group | 0 | 0 | 0 | 0 | 0.00 |
Earnings and Valuation
This table compares Hims & Hers Health and SBC Medical Group”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Hims & Hers Health | $1.24 billion | 4.86 | -$23.55 million | $0.44 | 62.75 |
| SBC Medical Group | $223.34 million | 2.48 | $340,000.00 | N/A | N/A |
SBC Medical Group has lower revenue, but higher earnings than Hims & Hers Health.
Insider and Institutional Ownership
63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 63.9% of SBC Medical Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Hims & Hers Health and SBC Medical Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Hims & Hers Health | 8.19% | 10.97% | 8.29% |
| SBC Medical Group | N/A | -11.59% | -7.05% |
Summary
Hims & Hers Health beats SBC Medical Group on 10 of the 12 factors compared between the two stocks.
About Hims & Hers Health
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.
About SBC Medical Group
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.
Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.com's FREE daily email newsletter.
